LEXICON PHARMACEUTICALS, INC.
LXRX
30 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Feb 27 1:33 PM | Raymond DebbaneDirector | Purchase | 2,000 | $1.49 | $3.0K | 1,906,186(D) | View → |
| Feb 23, 2026 | Feb 25 12:00 PM | Raymond DebbaneDirector | Purchase | 100,000 | $1.47 | $147.0K | 1,904,186(D) | View → |
| Feb 20, 2026 | Feb 23 12:49 PM | Raymond DebbaneDirector | Purchase | 100,000 | $1.48 | $147.8K | 1,804,186(D) | View → |
| Feb 19, 2026 | Feb 23 12:49 PM | Raymond DebbaneDirector | Purchase | 50,000 | $1.44 | $72.0K | 1,704,186(D) | View → |
| Feb 18, 2026 | Feb 18 9:30 PM | Raymond DebbaneDirector | Purchase | 133,688 | $1.32 | $176.5K | 1,654,186(D) | View → |
| Feb 17, 2026 | Feb 18 9:30 PM | Raymond DebbaneDirector | Purchase | 76,857 | $1.31 | $100.5K | 1,520,498(D) | View → |
| Feb 13, 2026 | Feb 18 9:30 PM | Raymond DebbaneDirector | Purchase | 57,952 | $1.31 | $75.9K | 1,443,641(D) | View → |
| Feb 2, 2026 | Feb 4 9:25 PM | Invus Global Management, LLCDirector, 10% Owner | Purchase | 1,538,462 | $1.30 | $2.0M | 1,538,462(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | May 9 1:45 AM | Artal Participations S.a r.l.Director, 10% Owner | Option Exercise | 408,434.7 | — | 0(I) | View → |
| Apr 30, 2026 | May 9 1:45 AM | Artal Participations S.a r.l.Director, 10% Owner | Grant/Award | 408,434.7 | — | 408,434.7(I) | View → |
| May 1, 2026 | May 4 8:59 PM | Philippe AmouyalDirector | Grant/Award | 79,192 | $1.61 | 43,478(D) | View → |
| May 1, 2026 | May 4 8:57 PM | Christopher J SobeckiDirector | Grant/Award | 79,192 | $1.61 | 43,478(D) | View → |
| May 1, 2026 | May 4 8:32 PM | Sam L BarkerDirector | Grant/Award | 79,192 | $1.61 | 43,478(D) | View → |
| May 1, 2026 | May 4 8:30 PM | Ivan CheungDirector | Grant/Award | 79,192 | $1.61 | 43,478(D) | View → |
| May 1, 2026 | May 4 8:27 PM | Judith L SwainDirector | Grant/Award | 79,192 | $1.61 | 43,478(D) | View → |
| May 1, 2026 | May 4 8:20 PM | Diane E. SullivanDirector | Grant/Award | 79,192 | $1.61 | 43,478(D) | View → |
| May 1, 2026 | May 4 8:09 PM | Raymond DebbaneDirector | Grant/Award | 79,192 | $1.61 | 43,478(D) | View → |
| Feb 28, 2026 | Mar 3 12:20 PM | Wendy McdermottSVP, Human Resources | Option Exercise | 224,406 | — | 288,787(D) | View → |
| Feb 28, 2026 | Mar 3 12:20 PM | Rachel Yap MartensSVP, Partnerships & Corp Strat | Option Exercise | 67,090 | — | 134,180(D) | View → |
| Feb 28, 2026 | Mar 3 12:19 PM | Craig B GranowitzSVP, Chief Medical Officer | Option Exercise | 312,276 | — | 404,520(D) | View → |
| Feb 28, 2026 | Mar 3 12:18 PM | Suma GopinathanSVP, Discovery | Option Exercise | 99,950 | — | 131,280(D) | View → |
| Feb 28, 2026 | Mar 3 12:18 PM | Lisa DefrancescoSVP, IR and Corp Comm | Option Exercise | 152,864 | — | 256,380(D) | View → |
| Feb 28, 2026 | Mar 3 12:17 PM | Brian T CrumSVP, General Counsel & Secr. | Option Exercise | 273,006 | — | 340,327(D) | View → |
| Feb 28, 2026 | Mar 3 12:16 PM | Scott M CoianteSVP, Chief Financial Officer | Option Exercise | 160,237 | — | 320,473(D) | View → |
| Feb 28, 2026 | Mar 3 12:15 PM | Michael ExtonDirector, Chief Executive Officer | Option Exercise | 503,263 | — | 1,006,527(D) | View → |
| Feb 12, 2026 | Feb 17 9:10 PM | Wendy McdermottSVP, Human Resources | Grant/Award | 625,500 | $1.37 | 375,300(D) | View → |
| Feb 12, 2026 | Feb 17 9:10 PM | Rachel Yap MartensSVP, Partnerships & Corp Strat | Grant/Award | 484,360 | $1.37 | 290,620(D) | View → |
| Feb 12, 2026 | Feb 17 9:09 PM | Craig B GranowitzSVP, Chief Medical Officer | Grant/Award | 866,530 | $1.37 | 519,920(D) | View → |
Page 1 of 2
Next →